TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2017/08/30
-
Indian UGC (journal)
-
Refrences58
-
Citations72
-
Jiaqing Cao
-
Xinyou Han
-
Xin Qi
-
Xiangyun Jin
-
Xiaolin Li
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
You May Also Like
- Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
- Non-coding RNAs as regulators in epigenetics
- Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo
- Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
- Molecular mechanisms of Nrf2‐mediated antioxidant response
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up | Annals of Oncology |
| 149 | 2009 |
Long non‐coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR‐335‐5p in osteosarcoma cells | Cancer Science |
| 98 | 2017 |
| Long non-coding RNA TUG1 promotes endometrial cancer development via inhibiting miR-299 and miR-34a-5p | Oncotarget | 43 | 2017 | |
| Long noncoding RNAs: Re-writing dogmas of RNA processing and stability | Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms |
| 148 | 2016 |
| Noncoding RNAs: New players in cancers | 2016 |
Refrences Analysis
The category
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 25
is the most frequently represented among the references in this article. It primarily includes studies from Nature and Oncotarget. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Emerging roles of long non-coding RNAs in osteosarcoma | Frontiers in Molecular Biosciences |
| 2024 | |
Pre-Clinical Studies of MicroRNA-Based Therapies for Sepsis: A Scoping Review | Oxygen |
| 2024 | |
| miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses | Pathology - Research and Practice |
| 6 | 2023 |
Capsaicin Reduces Cancer Stemness and Inhibits Metastasis by Downregulating SOX2 and EZH2 in Osteosarcoma | The American Journal of Chinese Medicine |
| 2023 | |
Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1 | Molecular Cancer |
| 18 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 28
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Circular RNA EIF6 (Hsa_circ_0060060) sponges miR-144-3p to promote the cisplatin-resistance of human thyroid carcinoma cells by autophagy regulation and was published in 2018. The most recent citation comes from a 2024 study titled Emerging roles of long non-coding RNAs in osteosarcoma. This article reached its peak citation in 2020, with 15 citations. It has been cited in 61 different journals, 36% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.